P010 - Corporate FrontPage
ALK - Fighting the cause of allegy
Ready for a career at ALK?
View the share price development of the ALK share
Read more about R&D at ALK: Pipeline, Studies and Congresses
ALK is the first company to introduce tablet-based allergy vaccines. GRAZAX®, launched in 2006, treats grass pollen allergy
Read about the ALK history from the 1920s to the modern tablet-based allergy vaccines
How to apply for the WAO Henning Løwenstein Research Award 2009 - download guidelines here
Latest Releases